MARKSANS PHARMA LTDMARKSANS PHARMA LTDMARKSANS PHARMA LTD

MARKSANS PHARMA LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪75.59 B‬INR
‪2.66 B‬INR
‪18.51 B‬INR
‪204.48 M‬
Beta (1Y)
0.95

About MARKSANS PHARMA LTD

CEO
Mark Bosco Saldanha
Headquarters
Mumbai
Employees (FY)
‪1.4 K‬
Founded
1992
ISIN
INE750C01026
FIGI
BBG000D7VQM3
Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio includes tablets, hard capsules, soft gelatin capsules, oral liquids, and ointments. It operates through the following geographical segments: US and North America, Europe and UK, Australia and New Zealand, India, and Rest of World. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MARKSANS is 165.00 INR — it has decreased by 1.11% in the past 24 hours. Watch MARKSANS PHARMA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange MARKSANS PHARMA LTD stocks are traded under the ticker MARKSANS.
MARKSANS stock has risen by 5.16% compared to the previous week, the month change is a 1.43% fall, over the last year MARKSANS PHARMA LTD has showed a 120.88% increase.
MARKSANS reached its all-time high on Apr 18, 2024 with the price of 185.50 INR, and its all-time low was 1.30 INR and was reached on May 18, 2012. View more price dynamics on MARKSANS chart.
See other stocks reaching their highest and lowest prices.
MARKSANS stock is 2.07% volatile and has beta coefficient of 0.95. Track MARKSANS PHARMA LTD stock price on the chart and check out the list of the most volatile stocks — is MARKSANS PHARMA LTD there?
Today MARKSANS PHARMA LTD has the market capitalization of ‪75.59 B‬, it has decreased by 1.71% over the last week.
Yes, you can track MARKSANS PHARMA LTD financials in yearly and quarterly reports right on TradingView.
MARKSANS PHARMA LTD is going to release the next earnings report on May 30, 2024. Keep track of upcoming events with our Earnings Calendar.
MARKSANS net income for the last quarter is ‪832.35 M‬ INR, while the quarter before that showed ‪835.18 M‬ INR of net income which accounts for −0.34% change. Track more MARKSANS PHARMA LTD financial stats to get the full picture.
Yes, MARKSANS dividends are paid annually. The last dividend per share was 0.50 INR. As of today, Dividend Yield (TTM)% is 0.30%. Tracking MARKSANS PHARMA LTD dividends might help you take more informed decisions.
MARKSANS PHARMA LTD dividend yield was 0.71% in 2022, and payout ratio reached 7.80%. The year before the numbers were 0.55% and 5.54% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 22, 2024, the company has ‪1.40 K‬ employees. See our rating of the largest employees — is MARKSANS PHARMA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MARKSANS PHARMA LTD EBITDA is ‪4.58 B‬ INR, and current EBITDA margin is 18.99%. See more stats in MARKSANS PHARMA LTD financial statements.
Like other stocks, MARKSANS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MARKSANS PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MARKSANS PHARMA LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MARKSANS PHARMA LTD stock shows the buy signal. See more of MARKSANS PHARMA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.